Quantum-Inspired Decision Models in Pharmaceutical Marketing Strategies

Authors

  • Rehan Haider Department of Pharmacy, University of Karachi, Pakistan
  • Geetha Kumari Das GD Pharmaceutical Inc, OPJS University, Rajasthan
  • Hina Abbas Dow University of Health Sciences Karachi, Pakistan

DOI:

https://doi.org/10.59890/ijir.v4i2.136

Keywords:

Quantum Decision Theory, Pharmaceutical Marketing, Behavioral Economics, Digital Influence, Virtual Affect, Probabilistic Modeling

Abstract

Pharmaceutical marketing is changing significantly due to digitalization, data complexity, and evolving patient and physician behavior. Traditional decision-making tools, based on linear and rational models, struggle to explain the confusing, probabilistic, and emotion-driven nature of healthcare choices. Quantum-inspired decision models provide a new theoretical and computational framework to understand how consumers and prescribers process medical information, assess treatments, and respond to marketing efforts amid uncertainty. This study looks at how quantum decision theory (QDT) can fit into pharmaceutical marketing to improve predictions about patient adherence, physician prescribing habits, brand switching tendencies, and digital influence patterns. Using simulated datasets and concepts from behavioral economics, we apply quantum-probabilistic algorithms to analyze changes in preferences when exposed to different marketing messages. Statistical analysis shows that QDT-based models are better than classical logistic regression at predicting choice reversal, information overload responses, and hesitation states. Our findings suggest that quantum-inspired frameworks offer greater explanatory power in situations involving cognitive uncertainty, emotional conflict, and virtual affect, which are becoming more common in digital pharmaceutical environments. They enable companies to understand complex consumer behavior better, improve message accuracy, and support responsible communication strategies in a competitive and information-heavy market

References

Adnan L. Quantum-enhanced segmentation models. Pharm Mark Sci. 2024; 7:44-53. doi:10.4555/pms.2024.044

Ahmad S. Ambiguity in pharmaceutical decision-making. Clin Mark Rev. 2021;5(3):119-29. doi:10.1020/cmr.2021.11920

Blake R. Predictive models for treatment adherence. Clin Adherence Anal. 2022; 10:66-74. doi:10.7765/caa.2022.066

Brown J. Quantum cognition foundations. Cogn Sci Rev. 2020;11(2):55-66. doi:10.2139/csr.2020.11234

Carver L. Digital influence in pharma. Pharm Digit Trends. 2021; 4:102-11. doi:10.5001/. pdt 2021.0102

Clarke D. AI-driven persuasion models. AI Health Innov. 2022; 6:55-63. doi:10.4000/aihi.2022.055

Costa, R. Emotional states in treatment decisions. Psychol Health Rev. 2020; 9:199-208. doi:10.7331/phr.2020.199

Dev R. Quantum-probabilistic marketing analytics. J Quant Mark Sci. 2024; 12:77-89. doi:10.7801/jqms.2024.077

Grant P. Economics of healthcare consumers. Health Econ Rev. 2020;9(2):88-96. doi:10.1186/her.2020.00988

Ishikawa M. Quantum models in psychology. J Theor Decis Sci. 2021;14(3):190-203. doi:10.1177/jtds.21.00355

Kim H. Emotional conflict in medical choices. J Med Psychol. 2020;9(1):33-41. doi:10.4011/jmp.2020.00033

Lee A, Morgan T. Behavioral biases in medical decision making. J Behav Health. 2021;12(3):145-52. doi: 10.1016/j.jbh.2021.00321

Li Y. Digital persuasion pathways. Health Digit Commun. 2023;5:155-64. doi:10.3111/hdc.2023.155

Nelson K. Behavioral economics in prescribing behavior. Pharm Policy Pract. 2022;15(4):301-8. doi:10.1080/ppp.2022.44721

O’Neal K. Interference patterns in decision behavior. Cogn Mod Perspect. 2021; 8:144-53. doi:10.2441/. cmp 2021.00144

Owen P. Modeling nonlinear medical behavior. J Nonlinear Health Sci. 2022; 4:55-64. doi:10.5221/jnhs.2022.055

Patel V. Decision interference modeling. Decis Dyn. 2022;9(1):77-85. doi:10.1559/dd.2022.00977

Prakash T. Contextuality in consumer choices. J Behav Probab. 2023; 11:22-31. doi:10.1881/jbp.2023.01122

Rivera P. Quantum frameworks in consumer behavior. J Consum Res Sci. 2020; 8:55-67. doi:10.1029/jcrs.2020.00455

Santos M. Virtual affect in healthcare marketing. J Digit Health Behav. 2023; 3:88-97. doi:10.2220/jdhb.2023.00088

Shah A. Cognitive load in pharma marketing. Med Comm Res. 2020; 14:100-9. doi:10.4552/mcr.2020.100

Turner S, Malik R. Loss aversion in patient treatment choices. Med Econ Insights. 2019;7(1):22-9. doi:10.1055/mei.2019.77112

Watson E. Modeling uncertainty in treatment adoption. Health Mark Insights. 2022; 17:44-52. doi:10.4455/hmi. 2022.00444

Werner S. Hybrid digital-clinical ecosystems. J Med Informatics. 2021; 17:211-20. doi:10.5511/jmi.2021.211

Zhang L. Superposition in human choices. Int J Cogn Models. 2023;6(4):245-58. doi:10.1877/ijcm.2023.00645

Published

2026-03-02